231 related articles for article (PubMed ID: 27782867)
1. Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren's syndrome.
Lee KE; Kang JH; Yim YR; Kim JE; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Yoon KC; Lee JS; Lee SS
Clin Exp Rheumatol; 2017; 35(2):234-240. PubMed ID: 27782867
[TBL] [Abstract][Full Text] [Related]
2. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
3. The Significance of Ectopic Germinal Centers in the Minor Salivary Gland of Patients with Sjögren's Syndrome.
Lee KE; Kang JH; Yim YR; Kim JE; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Yoon KC; Lee JS; Lee SS
J Korean Med Sci; 2016 Feb; 31(2):190-5. PubMed ID: 26839471
[TBL] [Abstract][Full Text] [Related]
4. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
[TBL] [Abstract][Full Text] [Related]
6. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.
Barone F; Bombardieri M; Rosado MM; Morgan PR; Challacombe SJ; De Vita S; Carsetti R; Spencer J; Valesini G; Pitzalis C
J Immunol; 2008 Apr; 180(7):5130-40. PubMed ID: 18354239
[TBL] [Abstract][Full Text] [Related]
7. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study.
Carubbi F; Alunno A; Cipriani P; Di Benedetto P; Ruscitti P; Berardicurti O; Bartoloni E; Bistoni O; Caterbi S; Ciccia F; Triolo G; Gerli R; Giacomelli R
Semin Arthritis Rheum; 2014 Dec; 44(3):314-24. PubMed ID: 24935529
[TBL] [Abstract][Full Text] [Related]
8. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
Barone F; Bombardieri M; Manzo A; Blades MC; Morgan PR; Challacombe SJ; Valesini G; Pitzalis C
Arthritis Rheum; 2005 Jun; 52(6):1773-84. PubMed ID: 15934082
[TBL] [Abstract][Full Text] [Related]
9. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
10. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
11. Detection of HTLV-1 in the labial salivary glands of patients with Sjögren’s syndrome: a distinct clinical subgroup?
Lee SJ; Lee JS; Shin MG; Tanaka Y; Park DJ; Kim TJ; Park YW; Lee SS
J Rheumatol; 2012 Apr; 39(4):809-15. PubMed ID: 22382336
[TBL] [Abstract][Full Text] [Related]
12. Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjögren's syndrome patients.
Tandon M; Perez P; Burbelo PD; Calkins C; Alevizos I
Clin Exp Rheumatol; 2017; 35(5):777-785. PubMed ID: 28421997
[TBL] [Abstract][Full Text] [Related]
13. Elastographic ultrasound: an additional image tool in Sjögren's syndrome.
Kimura-Hayama E; Criales-Vera S; Azpeitia-Espinosa L; Pacheco-Molina C; Reyes E; Lima G; Hernandez-Ramirez D; Llorente L; Hernandez-Molina G
Int J Rheum Dis; 2018 Jun; 21(6):1293-1300. PubMed ID: 29624878
[TBL] [Abstract][Full Text] [Related]
14. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
Zhou W; Dong Y; Zhao Y; Tang FL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
[TBL] [Abstract][Full Text] [Related]
15. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
16. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome.
Ek M; Popovic K; Harris HE; Nauclér CS; Wahren-Herlenius M
Arthritis Rheum; 2006 Jul; 54(7):2289-94. PubMed ID: 16802368
[TBL] [Abstract][Full Text] [Related]
17. Thymosin β
Bosello S; Peluso G; Iavarone F; Tolusso B; Messana I; Faa G; Castagnola M; Ferraccioli G
Arthritis Res Ther; 2016 Oct; 18(1):229. PubMed ID: 27716395
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome.
Risselada AP; Kruize AA; Goldschmeding R; Lafeber FP; Bijlsma JW; van Roon JA
Ann Rheum Dis; 2014 Aug; 73(8):1537-40. PubMed ID: 24525912
[TBL] [Abstract][Full Text] [Related]
19. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
[TBL] [Abstract][Full Text] [Related]
20. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
